

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.66840074 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.44629226 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.44629226 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.44629226 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.44629226 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.44629226 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.44629226 |
| 8 | response to peptidoglycan (GO:0032494) | 5.14484682 |
| 9 | detection of other organism (GO:0098543) | 4.96300596 |
| 10 | neutrophil mediated immunity (GO:0002446) | 4.95832634 |
| 11 | respiratory burst (GO:0045730) | 4.88051500 |
| 12 | detection of bacterium (GO:0016045) | 4.85535764 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.72184086 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.67864589 |
| 15 | negative regulation of phagocytosis (GO:0050765) | 4.61089810 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.56002857 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.48370365 |
| 18 | positive regulation of B cell differentiation (GO:0045579) | 4.32452006 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.31636317 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.26314188 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.26314188 |
| 22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.26283517 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.26153958 |
| 24 | response to fungus (GO:0009620) | 4.22919606 |
| 25 | neutrophil activation (GO:0042119) | 4.15098463 |
| 26 | cellular extravasation (GO:0045123) | 4.14307996 |
| 27 | leukocyte aggregation (GO:0070486) | 4.12407348 |
| 28 | detection of external biotic stimulus (GO:0098581) | 4.04902009 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.01361350 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00977700 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.94867324 |
| 32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.93857640 |
| 33 | granulocyte activation (GO:0036230) | 3.92128072 |
| 34 | response to host immune response (GO:0052572) | 3.89859959 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.89859959 |
| 36 | myeloid leukocyte mediated immunity (GO:0002444) | 3.86529005 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.84470473 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.83181239 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.82969722 |
| 40 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.76731807 |
| 41 | negative regulation of granulocyte differentiation (GO:0030853) | 3.76333583 |
| 42 | defense response to fungus (GO:0050832) | 3.74919044 |
| 43 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.70802852 |
| 44 | positive regulation of interferon-alpha production (GO:0032727) | 3.68250657 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.64967201 |
| 46 | detection of biotic stimulus (GO:0009595) | 3.63791845 |
| 47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.62988449 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.55665366 |
| 49 | response to host (GO:0075136) | 3.55665366 |
| 50 | response to host defenses (GO:0052200) | 3.55665366 |
| 51 | positive regulation of mast cell activation (GO:0033005) | 3.54404410 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.54287290 |
| 53 | regulation of B cell differentiation (GO:0045577) | 3.54218286 |
| 54 | pinocytosis (GO:0006907) | 3.50492689 |
| 55 | positive thymic T cell selection (GO:0045059) | 3.48705688 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 3.46772783 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.46507557 |
| 58 | response to interleukin-15 (GO:0070672) | 3.44020924 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 3.43693416 |
| 60 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.35683056 |
| 61 | * regulation of mast cell activation (GO:0033003) | 3.35611950 |
| 62 | defense response to protozoan (GO:0042832) | 3.33993361 |
| 63 | leukocyte mediated cytotoxicity (GO:0001909) | 3.32686144 |
| 64 | positive regulation of mast cell degranulation (GO:0043306) | 3.31144339 |
| 65 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.31144339 |
| 66 | B cell mediated immunity (GO:0019724) | 3.30461963 |
| 67 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.30297426 |
| 68 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.30297426 |
| 69 | * regulation of mast cell degranulation (GO:0043304) | 3.29642618 |
| 70 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.24255038 |
| 71 | negative regulation of cell killing (GO:0031342) | 3.24255038 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 3.22699798 |
| 73 | B cell receptor signaling pathway (GO:0050853) | 3.22269746 |
| 74 | leukotriene metabolic process (GO:0006691) | 3.22132113 |
| 75 | cellular response to interleukin-15 (GO:0071350) | 3.20629871 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.19535123 |
| 77 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18719887 |
| 78 | reactive oxygen species biosynthetic process (GO:1903409) | 3.18199227 |
| 79 | negative regulation of innate immune response (GO:0045824) | 3.18126399 |
| 80 | response to protozoan (GO:0001562) | 3.17996859 |
| 81 | negative regulation of growth of symbiont in host (GO:0044130) | 3.17762518 |
| 82 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.17762518 |
| 83 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.17762518 |
| 84 | regulation of growth of symbiont in host (GO:0044126) | 3.17762518 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.16276088 |
| 86 | regulation of antigen processing and presentation (GO:0002577) | 3.16081930 |
| 87 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.15984606 |
| 88 | macrophage differentiation (GO:0030225) | 3.14245991 |
| 89 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13384973 |
| 90 | * regulation of mast cell activation involved in immune response (GO:0033006) | 3.12996481 |
| 91 | microglial cell activation (GO:0001774) | 3.11071796 |
| 92 | leukocyte degranulation (GO:0043299) | 3.10294369 |
| 93 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.09547939 |
| 94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07817369 |
| 95 | superoxide anion generation (GO:0042554) | 3.06379040 |
| 96 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03715573 |
| 97 | negative thymic T cell selection (GO:0045060) | 3.01074035 |
| 98 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.98964566 |
| 99 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98825343 |
| 100 | neutrophil chemotaxis (GO:0030593) | 2.96587631 |
| 101 | myeloid dendritic cell activation (GO:0001773) | 2.96249219 |
| 102 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.95368223 |
| 103 | macrophage activation (GO:0042116) | 2.95034115 |
| 104 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92505351 |
| 105 | germinal center formation (GO:0002467) | 2.92154802 |
| 106 | mast cell activation (GO:0045576) | 2.91501462 |
| 107 | tolerance induction (GO:0002507) | 2.90495277 |
| 108 | myeloid leukocyte activation (GO:0002274) | 2.89055334 |
| 109 | neutrophil migration (GO:1990266) | 2.87587124 |
| 110 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.85778141 |
| 111 | * regulation of regulated secretory pathway (GO:1903305) | 2.85597509 |
| 112 | response to type I interferon (GO:0034340) | 2.85323637 |
| 113 | cellular response to type I interferon (GO:0071357) | 2.85284320 |
| 114 | type I interferon signaling pathway (GO:0060337) | 2.85284320 |
| 115 | mannose metabolic process (GO:0006013) | 2.83499100 |
| 116 | negative T cell selection (GO:0043383) | 2.82033048 |
| 117 | response to interferon-beta (GO:0035456) | 2.81188786 |
| 118 | regulation of tolerance induction (GO:0002643) | 2.81068408 |
| 119 | * regulation of leukocyte degranulation (GO:0043300) | 2.79271300 |
| 120 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.78275177 |
| 121 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.77225366 |
| 122 | negative regulation of interleukin-17 production (GO:0032700) | 2.76584951 |
| 123 | cellular response to zinc ion (GO:0071294) | 2.76143176 |
| 124 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.75812276 |
| 125 | positive regulation of interferon-beta production (GO:0032728) | 2.75582506 |
| 126 | negative regulation of mast cell activation (GO:0033004) | 2.75346199 |
| 127 | T cell selection (GO:0045058) | 2.73671566 |
| 128 | negative regulation of interleukin-6 production (GO:0032715) | 2.73292993 |
| 129 | T cell migration (GO:0072678) | 2.71684103 |
| 130 | leukocyte cell-cell adhesion (GO:0007159) | 2.70351284 |
| 131 | actin nucleation (GO:0045010) | 2.69772583 |
| 132 | regulation of phagocytosis (GO:0050764) | 2.67768305 |
| 133 | megakaryocyte development (GO:0035855) | 2.67209515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.01628553 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.96675034 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.70899508 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.94266944 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.92392174 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.67309792 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.65456959 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.53746490 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.24291938 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24069527 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.07528988 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.06200931 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.90751392 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.87803797 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80989066 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.75300836 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69180331 |
| 18 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.59188891 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.57686688 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.53962477 |
| 21 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.35401302 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32972320 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.30723301 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.24649364 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.23560780 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19043005 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14000258 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13525803 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.10920708 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05580599 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98551651 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.97134649 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.96736972 |
| 34 | * MAF_26560356_Chip-Seq_TH1_Human | 1.91372469 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.83355509 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.78462831 |
| 37 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76002294 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71189894 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70220660 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.67259507 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.64571629 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64106293 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63385813 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60994498 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60380662 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.60334746 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56826158 |
| 48 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.56555459 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56419386 |
| 50 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.54924893 |
| 51 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.54528721 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51987524 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50567639 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50510413 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49964698 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46367660 |
| 57 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44766188 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43597053 |
| 59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.41459578 |
| 60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33368186 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31547173 |
| 62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.31281153 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30657499 |
| 64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.29842110 |
| 65 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27317134 |
| 66 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26648298 |
| 67 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26166721 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24492793 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23439357 |
| 70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23198388 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22368701 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20072482 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19035173 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18808166 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12655145 |
| 76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12394609 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12281153 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12217149 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12036572 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11272466 |
| 81 | * MAF_26560356_Chip-Seq_TH2_Human | 1.10965684 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10771586 |
| 83 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09138250 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09070046 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07503040 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06381832 |
| 87 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.06121466 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05787984 |
| 89 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02674153 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02435018 |
| 91 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01828541 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01613841 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01562875 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01417174 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00012375 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99673848 |
| 97 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.95814757 |
| 98 | P68_20966046_ChIP-Seq_HELA_Human | 0.95314306 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91467423 |
| 100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90431478 |
| 101 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90008923 |
| 102 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.89250911 |
| 103 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.89047437 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87848010 |
| 105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87666073 |
| 106 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86394289 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83553388 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77448787 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76455220 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76175101 |
| 111 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75045590 |
| 112 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.74366997 |
| 113 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.74207457 |
| 114 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.73551059 |
| 115 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.73399287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.03895375 |
| 2 | MP0003436_decreased_susceptibility_to | 3.65816852 |
| 3 | MP0003303_peritoneal_inflammation | 3.52766780 |
| 4 | * MP0002419_abnormal_innate_immunity | 3.16698077 |
| 5 | MP0009785_altered_susceptibility_to | 3.01703008 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.97793632 |
| 7 | * MP0005025_abnormal_response_to | 2.77239865 |
| 8 | MP0005464_abnormal_platelet_physiology | 2.74357193 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.68216980 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.66674058 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.65196120 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.54892287 |
| 13 | MP0001800_abnormal_humoral_immune | 2.51845288 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.46367701 |
| 15 | MP0000685_abnormal_immune_system | 2.44643135 |
| 16 | MP0005387_immune_system_phenotype | 2.43084122 |
| 17 | MP0001790_abnormal_immune_system | 2.43084122 |
| 18 | MP0003724_increased_susceptibility_to | 2.39241644 |
| 19 | MP0002723_abnormal_immune_serum | 2.38597205 |
| 20 | MP0005671_abnormal_response_to | 2.37004933 |
| 21 | * MP0001819_abnormal_immune_cell | 2.33032744 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.33018807 |
| 23 | MP0005174_abnormal_tail_pigmentation | 2.23814053 |
| 24 | MP0000569_abnormal_digit_pigmentation | 2.22799024 |
| 25 | MP0009278_abnormal_bone_marrow | 2.18573287 |
| 26 | MP0006082_CNS_inflammation | 2.13999262 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 2.10225381 |
| 28 | MP0001545_abnormal_hematopoietic_system | 2.10225381 |
| 29 | MP0003183_abnormal_peptide_metabolism | 2.05498393 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.99260253 |
| 31 | MP0001853_heart_inflammation | 1.95825162 |
| 32 | MP0002405_respiratory_system_inflammati | 1.95375939 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.90937465 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.90880773 |
| 35 | * MP0002398_abnormal_bone_marrow | 1.87227212 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.86700245 |
| 37 | * MP0000716_abnormal_immune_system | 1.82833082 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.81210781 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.77295789 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.71808645 |
| 41 | MP0004510_myositis | 1.70196804 |
| 42 | MP0000343_altered_response_to | 1.69264067 |
| 43 | MP0009840_abnormal_foam_cell | 1.61385929 |
| 44 | * MP0002429_abnormal_blood_cell | 1.58030662 |
| 45 | MP0002006_tumorigenesis | 1.57577737 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.55969761 |
| 47 | * MP0002722_abnormal_immune_system | 1.55463459 |
| 48 | MP0008469_abnormal_protein_level | 1.55442222 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.54790131 |
| 50 | MP0001873_stomach_inflammation | 1.50206279 |
| 51 | MP0002132_abnormal_respiratory_system | 1.50133746 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.47084492 |
| 53 | MP0004947_skin_inflammation | 1.44753021 |
| 54 | * MP0000465_gastrointestinal_hemorrhage | 1.43116460 |
| 55 | MP0003075_altered_response_to | 1.39970796 |
| 56 | MP0000490_abnormal_crypts_of | 1.33307112 |
| 57 | MP0000858_altered_metastatic_potential | 1.31201277 |
| 58 | MP0003448_altered_tumor_morphology | 1.25103663 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.22413564 |
| 60 | MP0005451_abnormal_body_composition | 1.20360874 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.19925816 |
| 62 | MP0009764_decreased_sensitivity_to | 1.18796275 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.15694653 |
| 64 | MP0002933_joint_inflammation | 1.13758100 |
| 65 | MP0003828_pulmonary_edema | 1.12383679 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.07204367 |
| 67 | MP0005310_abnormal_salivary_gland | 1.03795494 |
| 68 | * MP0001851_eye_inflammation | 1.01514074 |
| 69 | MP0002009_preneoplasia | 0.97746801 |
| 70 | * MP0000703_abnormal_thymus_morphology | 0.97656622 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.97570166 |
| 72 | MP0000371_diluted_coat_color | 0.96037218 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.95608321 |
| 74 | MP0008004_abnormal_stomach_pH | 0.94951695 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.93602258 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 0.92593876 |
| 77 | MP0009763_increased_sensitivity_to | 0.90229037 |
| 78 | MP0003866_abnormal_defecation | 0.89794549 |
| 79 | MP0004381_abnormal_hair_follicle | 0.89255555 |
| 80 | MP0000249_abnormal_blood_vessel | 0.87881237 |
| 81 | MP0005166_decreased_susceptibility_to | 0.86332495 |
| 82 | MP0003693_abnormal_embryo_hatching | 0.86258293 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.86108630 |
| 84 | MP0005390_skeleton_phenotype | 0.85311177 |
| 85 | MP0008057_abnormal_DNA_replication | 0.84616059 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.83711616 |
| 87 | * MP0010307_abnormal_tumor_latency | 0.83590504 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.75353449 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.75311200 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.74889076 |
| 91 | MP0001663_abnormal_digestive_system | 0.73996244 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.73599403 |
| 93 | MP0005023_abnormal_wound_healing | 0.72858193 |
| 94 | MP0003690_abnormal_glial_cell | 0.71620009 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.70294522 |
| 96 | MP0008260_abnormal_autophagy | 0.67857868 |
| 97 | MP0000604_amyloidosis | 0.67011038 |
| 98 | MP0005164_abnormal_response_to | 0.65895819 |
| 99 | MP0001958_emphysema | 0.64708760 |
| 100 | MP0003279_aneurysm | 0.64221269 |
| 101 | MP0008007_abnormal_cellular_replicative | 0.63693117 |
| 102 | MP0005076_abnormal_cell_differentiation | 0.63600963 |
| 103 | MP0003186_abnormal_redox_activity | 0.61560880 |
| 104 | MP0003795_abnormal_bone_structure | 0.59906852 |
| 105 | MP0000609_abnormal_liver_physiology | 0.59089134 |
| 106 | MP0005165_increased_susceptibility_to | 0.59050819 |
| 107 | MP0004883_abnormal_blood_vessel | 0.57989997 |
| 108 | MP0008873_increased_physiological_sensi | 0.57736716 |
| 109 | MP0002928_abnormal_bile_duct | 0.57179107 |
| 110 | MP0000313_abnormal_cell_death | 0.55323978 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.55025909 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.54981938 |
| 113 | MP0000598_abnormal_liver_morphology | 0.54021847 |
| 114 | MP0008874_decreased_physiological_sensi | 0.52440062 |
| 115 | MP0005083_abnormal_biliary_tract | 0.51107612 |
| 116 | MP0006054_spinal_hemorrhage | 0.51066194 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48399727 |
| 118 | MP0005535_abnormal_body_temperature | 0.47553774 |
| 119 | MP0004130_abnormal_muscle_cell | 0.46631634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.28400310 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.67486985 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.35461101 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.26829834 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.56950324 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.39656164 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.34169034 |
| 8 | Myositis (HP:0100614) | 4.31004254 |
| 9 | Recurrent skin infections (HP:0001581) | 4.18274309 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.13695427 |
| 11 | Obstructive lung disease (HP:0006536) | 4.13695427 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.07698354 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.97261422 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.92198930 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.76798633 |
| 16 | Gingivitis (HP:0000230) | 3.73003404 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.65702680 |
| 18 | Spontaneous hematomas (HP:0007420) | 3.49988729 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.48095721 |
| 20 | Cellulitis (HP:0100658) | 3.42559133 |
| 21 | IgM deficiency (HP:0002850) | 3.35417821 |
| 22 | Orchitis (HP:0100796) | 3.33121322 |
| 23 | Thrombocytosis (HP:0001894) | 3.28611468 |
| 24 | Encephalitis (HP:0002383) | 3.28247989 |
| 25 | Chronic otitis media (HP:0000389) | 3.24259996 |
| 26 | Periodontitis (HP:0000704) | 3.20547717 |
| 27 | Petechiae (HP:0000967) | 3.18806951 |
| 28 | Amyloidosis (HP:0011034) | 3.17595341 |
| 29 | Meningitis (HP:0001287) | 3.17580548 |
| 30 | Dysostosis multiplex (HP:0000943) | 3.15343704 |
| 31 | Recurrent viral infections (HP:0004429) | 3.14366356 |
| 32 | Prolonged bleeding time (HP:0003010) | 3.09509939 |
| 33 | Hematochezia (HP:0002573) | 3.07387743 |
| 34 | Keratoconjunctivitis (HP:0001096) | 3.01250398 |
| 35 | Vasculitis (HP:0002633) | 2.91456313 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90992219 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90992219 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 2.90160113 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.85985914 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.85985914 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.85985914 |
| 42 | Epistaxis (HP:0000421) | 2.85189134 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.82130662 |
| 44 | Optic neuritis (HP:0100653) | 2.82130662 |
| 45 | Glomerulonephritis (HP:0000099) | 2.80963756 |
| 46 | Osteomyelitis (HP:0002754) | 2.75621197 |
| 47 | Axonal loss (HP:0003447) | 2.72078847 |
| 48 | Gingival bleeding (HP:0000225) | 2.69061283 |
| 49 | Abnormality of the prostate (HP:0008775) | 2.65979851 |
| 50 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.65140938 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.64716836 |
| 52 | Urticaria (HP:0001025) | 2.64633718 |
| 53 | Hypochromic anemia (HP:0001931) | 2.62494880 |
| 54 | Abnormal platelet function (HP:0011869) | 2.61166749 |
| 55 | Impaired platelet aggregation (HP:0003540) | 2.61166749 |
| 56 | Stomatitis (HP:0010280) | 2.60070989 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.59812148 |
| 58 | Disinhibition (HP:0000734) | 2.59658214 |
| 59 | Episodic fever (HP:0001954) | 2.59333025 |
| 60 | Arterial thrombosis (HP:0004420) | 2.58689884 |
| 61 | Agnosia (HP:0010524) | 2.58433122 |
| 62 | Pustule (HP:0200039) | 2.58120942 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.56764357 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56764357 |
| 65 | T lymphocytopenia (HP:0005403) | 2.54668488 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.51988335 |
| 67 | J-shaped sella turcica (HP:0002680) | 2.50478752 |
| 68 | Increased serum ferritin (HP:0003281) | 2.50189897 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.49410793 |
| 70 | Gastrointestinal inflammation (HP:0004386) | 2.48786741 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.48681214 |
| 72 | Thoracic kyphosis (HP:0002942) | 2.48503818 |
| 73 | Leukocytosis (HP:0001974) | 2.48371264 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.47635720 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.47635720 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.47635720 |
| 77 | Basal ganglia calcification (HP:0002135) | 2.47464372 |
| 78 | Abnormality of T cells (HP:0002843) | 2.47011082 |
| 79 | Chest pain (HP:0100749) | 2.46825753 |
| 80 | Abnormality of T cell number (HP:0011839) | 2.45503854 |
| 81 | Hemoptysis (HP:0002105) | 2.44392015 |
| 82 | Anorexia (HP:0002039) | 2.43208387 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.39953037 |
| 84 | Loss of speech (HP:0002371) | 2.38540131 |
| 85 | Colitis (HP:0002583) | 2.36192942 |
| 86 | Hepatosplenomegaly (HP:0001433) | 2.31833770 |
| 87 | Pulmonary infiltrates (HP:0002113) | 2.26337161 |
| 88 | Abnormality of the pleura (HP:0002103) | 2.25728391 |
| 89 | Increased IgM level (HP:0003496) | 2.23348060 |
| 90 | Eosinophilia (HP:0001880) | 2.20782927 |
| 91 | Abnormality of the nasal mucosa (HP:0000433) | 2.19581028 |
| 92 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.18154821 |
| 93 | Recurrent pneumonia (HP:0006532) | 2.17402200 |
| 94 | Gangrene (HP:0100758) | 2.15252068 |
| 95 | Abnormality of the thoracic spine (HP:0100711) | 2.14153521 |
| 96 | Vertigo (HP:0002321) | 2.13696800 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 2.13333085 |
| 98 | Nasal polyposis (HP:0100582) | 2.13099992 |
| 99 | Granulocytopenia (HP:0001913) | 2.11045471 |
| 100 | Microcytic anemia (HP:0001935) | 2.10588172 |
| 101 | Abnormal platelet volume (HP:0011876) | 2.09815166 |
| 102 | Glomerulopathy (HP:0100820) | 2.09776868 |
| 103 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09114666 |
| 104 | Abnormality of T cell physiology (HP:0011840) | 2.08912487 |
| 105 | Thyroiditis (HP:0100646) | 2.06913989 |
| 106 | Skin ulcer (HP:0200042) | 2.06769640 |
| 107 | Albinism (HP:0001022) | 2.05872136 |
| 108 | Pathologic fracture (HP:0002756) | 2.01827488 |
| 109 | Thrombophlebitis (HP:0004418) | 2.01510634 |
| 110 | Skin rash (HP:0000988) | 2.01212371 |
| 111 | Prostate neoplasm (HP:0100787) | 2.00576813 |
| 112 | Polyneuropathy (HP:0001271) | 2.00160615 |
| 113 | Peritonitis (HP:0002586) | 1.99859865 |
| 114 | Increased IgE level (HP:0003212) | 1.98585677 |
| 115 | Abnormality of the peritoneum (HP:0002585) | 1.98220933 |
| 116 | Joint hemorrhage (HP:0005261) | 1.97913676 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 1.96829964 |
| 118 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96135516 |
| 119 | Sepsis (HP:0100806) | 1.95068457 |
| 120 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93921330 |
| 121 | Premature loss of primary teeth (HP:0006323) | 1.93443308 |
| 122 | Polycythemia (HP:0001901) | 1.93230516 |
| 123 | Deformed sella turcica (HP:0002681) | 1.92688747 |
| 124 | Pulmonary embolism (HP:0002204) | 1.91280417 |
| 125 | Menorrhagia (HP:0000132) | 1.90534900 |
| 126 | Abnormality of the lumbar spine (HP:0100712) | 1.89293715 |
| 127 | Cheilitis (HP:0100825) | 1.87293757 |
| 128 | Purpura (HP:0000979) | 1.84881796 |
| 129 | Nephritis (HP:0000123) | 1.84670920 |
| 130 | Restrictive lung disease (HP:0002091) | 1.82801611 |
| 131 | Panhypogammaglobulinemia (HP:0003139) | 1.81659127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 3.87721858 |
| 2 | MAP4K1 | 3.71508416 |
| 3 | BLK | 3.22076878 |
| 4 | KIT | 3.13019060 |
| 5 | RIPK4 | 2.82637772 |
| 6 | IRAK3 | 2.56938660 |
| 7 | TYK2 | 2.54421265 |
| 8 | TAOK3 | 2.50077340 |
| 9 | ERN1 | 2.46859705 |
| 10 | BTK | 2.36588364 |
| 11 | TBK1 | 2.25364467 |
| 12 | TEC | 2.22658922 |
| 13 | PRPF4B | 2.18351557 |
| 14 | CSF1R | 2.17813720 |
| 15 | MAP2K3 | 2.06514542 |
| 16 | TGFBR2 | 2.06406030 |
| 17 | MAP3K14 | 2.00518121 |
| 18 | ZAP70 | 1.87419422 |
| 19 | EPHB1 | 1.67644378 |
| 20 | SYK | 1.66613143 |
| 21 | TXK | 1.66208215 |
| 22 | PIM2 | 1.63599807 |
| 23 | IKBKE | 1.57395229 |
| 24 | JAK3 | 1.54598601 |
| 25 | IKBKB | 1.53676741 |
| 26 | CSK | 1.49920972 |
| 27 | CLK1 | 1.46952064 |
| 28 | * HCK | 1.41224189 |
| 29 | TAOK1 | 1.38941096 |
| 30 | LYN | 1.32621359 |
| 31 | STK10 | 1.28754687 |
| 32 | EEF2K | 1.28092609 |
| 33 | FLT3 | 1.25656591 |
| 34 | LCK | 1.24492348 |
| 35 | JAK1 | 1.22981436 |
| 36 | PKN2 | 1.21704713 |
| 37 | CAMK1D | 1.18881922 |
| 38 | NME2 | 1.18613681 |
| 39 | TRPM7 | 1.18221999 |
| 40 | MAP3K1 | 1.16892055 |
| 41 | MATK | 1.15865101 |
| 42 | KDR | 1.09474971 |
| 43 | TTN | 1.07934930 |
| 44 | PAK4 | 1.05322260 |
| 45 | PIM1 | 1.04477092 |
| 46 | TAOK2 | 1.03688783 |
| 47 | ITK | 1.02972152 |
| 48 | SIK2 | 0.99566273 |
| 49 | GRK6 | 0.95953824 |
| 50 | MAP2K2 | 0.94116301 |
| 51 | SIK3 | 0.93056543 |
| 52 | BMPR2 | 0.90136331 |
| 53 | MARK2 | 0.89815284 |
| 54 | MAP3K11 | 0.89250077 |
| 55 | TRIB3 | 0.87996386 |
| 56 | LRRK2 | 0.86290491 |
| 57 | MAPK7 | 0.82568223 |
| 58 | PTK6 | 0.79936028 |
| 59 | MAP3K7 | 0.79773172 |
| 60 | MAPK12 | 0.79405983 |
| 61 | MAP3K13 | 0.76751967 |
| 62 | PRKD2 | 0.76591464 |
| 63 | JAK2 | 0.76520239 |
| 64 | FGR | 0.76492247 |
| 65 | PDK1 | 0.76469403 |
| 66 | RPS6KA4 | 0.75733944 |
| 67 | CAMK1G | 0.75241880 |
| 68 | IRAK1 | 0.73761947 |
| 69 | NEK9 | 0.72810128 |
| 70 | RPS6KA6 | 0.72165859 |
| 71 | PDPK1 | 0.70963008 |
| 72 | SCYL2 | 0.70885253 |
| 73 | * FES | 0.70194349 |
| 74 | FRK | 0.68997256 |
| 75 | CAMKK2 | 0.68487849 |
| 76 | STK4 | 0.68142042 |
| 77 | EIF2AK3 | 0.67679540 |
| 78 | TESK2 | 0.63771215 |
| 79 | PRKCQ | 0.63499207 |
| 80 | RPS6KL1 | 0.62907805 |
| 81 | RPS6KC1 | 0.62907805 |
| 82 | CHUK | 0.61927297 |
| 83 | MAPK4 | 0.61462507 |
| 84 | YES1 | 0.59995916 |
| 85 | MAP3K3 | 0.59880331 |
| 86 | FYN | 0.59302641 |
| 87 | CDK19 | 0.59112049 |
| 88 | FGFR3 | 0.59055671 |
| 89 | CDC42BPA | 0.58602335 |
| 90 | IRAK2 | 0.56714244 |
| 91 | SMG1 | 0.56199016 |
| 92 | EIF2AK2 | 0.55371487 |
| 93 | HIPK2 | 0.54515828 |
| 94 | RIPK1 | 0.54095285 |
| 95 | STK16 | 0.54020523 |
| 96 | CDK6 | 0.53709610 |
| 97 | NEK2 | 0.52818607 |
| 98 | TIE1 | 0.52734000 |
| 99 | MARK3 | 0.51486453 |
| 100 | PIK3CG | 0.50453823 |
| 101 | PRKCD | 0.50307618 |
| 102 | MAP2K6 | 0.48464574 |
| 103 | MAPKAPK2 | 0.48273698 |
| 104 | ABL1 | 0.47935855 |
| 105 | KSR2 | 0.47703877 |
| 106 | MAP3K6 | 0.46242179 |
| 107 | TGFBR1 | 0.46090758 |
| 108 | VRK1 | 0.45416106 |
| 109 | DYRK1B | 0.45157821 |
| 110 | TNK2 | 0.44284045 |
| 111 | PTK2B | 0.43841098 |
| 112 | ATR | 0.43528494 |
| 113 | MAP3K8 | 0.42751022 |
| 114 | RPS6KA2 | 0.42703324 |
| 115 | WEE1 | 0.40123119 |
| 116 | EPHA3 | 0.40066598 |
| 117 | EGFR | 0.39519978 |
| 118 | BCKDK | 0.38813764 |
| 119 | GRK7 | 0.37021842 |
| 120 | CDK4 | 0.36195082 |
| 121 | CDK7 | 0.35659395 |
| 122 | MAP2K4 | 0.35455244 |
| 123 | CDK12 | 0.35111851 |
| 124 | MAPKAPK3 | 0.34216752 |
| 125 | RET | 0.33590791 |
| 126 | DAPK2 | 0.33398011 |
| 127 | PRKG2 | 0.32996320 |
| 128 | MAPK11 | 0.32951411 |
| 129 | STK11 | 0.31616374 |
| 130 | MAPK3 | 0.31110446 |
| 131 | RPS6KA1 | 0.30896756 |
| 132 | MAP3K10 | 0.29312620 |
| 133 | BMX | 0.28625916 |
| 134 | MAP3K12 | 0.28492120 |
| 135 | MAP3K5 | 0.28407028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.27224987 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.93774302 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.92966146 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.55701909 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51509010 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21342848 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.19113249 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.17415915 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06157156 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.01454008 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97417114 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94795633 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.92798387 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.91670433 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.91585092 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.91067374 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.88921956 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.84302984 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.80089451 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79339522 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.79184898 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.75558823 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74446809 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.70779652 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.64413235 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60744177 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59463465 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58311952 |
| 29 | DNA replication_Homo sapiens_hsa03030 | 1.53996675 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52795073 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.51838627 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48940598 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.45136883 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43512989 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.41528568 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.40160943 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35152458 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34175658 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.31925011 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30896227 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.27957344 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26153782 |
| 43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.24198318 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23421260 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.16647424 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16457127 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13449079 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.13322704 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11577330 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09501273 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06130816 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97504162 |
| 53 | Base excision repair_Homo sapiens_hsa03410 | 0.95681727 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92595583 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91616697 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84473457 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82164228 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80713280 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.78863747 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78828050 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78291644 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77288316 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76406345 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73820806 |
| 65 | Ribosome_Homo sapiens_hsa03010 | 0.73463778 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71320463 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68881392 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67890820 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67516945 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67079403 |
| 71 | Homologous recombination_Homo sapiens_hsa03440 | 0.66882676 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.63909217 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60708982 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.57643669 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55646733 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53148030 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52904751 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52441142 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51460476 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50231421 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49517674 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48474142 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47321731 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46605840 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45432455 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44805633 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43471008 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42311878 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.42226712 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41215801 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39568954 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39207471 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39146095 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38594545 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38500929 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37503410 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37459268 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36630944 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36066131 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35517045 |
| 101 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35341659 |
| 102 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35192154 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.35005125 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34449704 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34006624 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33803051 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.32999554 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31441557 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31233972 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30467547 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30313536 |
| 112 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28551189 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.28351386 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28236415 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28009814 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27692670 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27437118 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27251502 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25453451 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23540994 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18711680 |

